Skip to content

A randomized controlled study and mechanism of intervention on FET outcome in patients with thin endometrium with kidney-Yang deficiency

A randomized controlled study and mechanism of intervention on FET outcome in patients with thin endometrium with kidney-Yang deficiency

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005737
Enrollment
Unknown
Registered
2022-03-17
Start date
2022-03-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thin endometrium

Interventions

Treatment group:Intermedicinal moxibustion umbilicus + Hormone replacement program
control group:Hormone replacement program

Sponsors

Shandong Traditional Chinese Medicine University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 42 Years

Inclusion criteria

Inclusion criteria: (1) Conform to the diagnostic criteria of infertility and thin endometrium and the TCM syndrome differentiation criteria of kidney-Yang deficiency; (2) 20 = age =42 years old; (3) Subjects did not use any steroid steroid drugs in the first 3 months; (4) 1 ~ 2 high-quality frozen embryos were obtained by ovulation induction program with antagonist; (5) Signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Women in lactation and pregnancy; (2) with polycystic ovary syndrome, endometriosis, hyperprolactinemia, uterine fibroids and other gynecological diseases; (3) Previous history of ovarian tumor or ovarian surgery; (4) Patients with serious diseases such as cardiovascular and cerebrovascular diseases, serious abnormalities of liver and kidney function and hematopoietic system, psychiatric patients; (5) Previous radiotherapy and chemotherapy history; (6) people who are allergic to umbilical therapy powder; (7) Lesions around the umbilicus should not be moxibustion; (8) Participants in other clinical trials; (9) Those who did not meet the inclusion criteria, could not receive the umbilical moxibustion treatment through drug separation according to the provisions, could not judge the efficacy or incomplete data affected the efficacy and safety judgment.

Design outcomes

Primary

MeasureTime frame
Endometrial thickness;

Countries

China

Contacts

Public ContactMa Yuxia

Shandong University of Traditional Chinese Medicin

PHDmayuxia@126.COM18364167369

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026